INS and type 1 diabetes mellitus: The EDITION JP1 was a 6 mo, multicenter, randomized, open-label, parallel-group study comparing the efficacy and safety of Glar-300 and Glar-100 in Japanese people with T1DM who were taking prior basal and mealtime insulin, with a 6 mo extension period.